Faculty members listed are those who have contributed to past or ongoing efforts with CMOD.
Eric Abadie, M.D., Director, Therapeutics Evaluation, AFSSAPS, European Medicines Agency (EMEA) Paris, France
Petar Alaupovic, Ph.D., Head, Lipid and Lipoprotein Laboratory, Oklahoma Medical Research Foundation
Christine Albert, M.D., MPH, Director, Center for Arrhythmia Prevention, Harvard Medical School Boston, MA
Michelle A. Albert, M.D., M.P.H. Assistant Professor of Medicine, Brigham and Women’s Hospital Harvard Medical School Boston, MA
Jonathan Allis, Ph.D. Global Head, Imaging Technology General Electric Healthcare
Pierre Amarenco, M.D. Department of Neurology and Stroke Centre Bichat - Claude Bernard University Hospital and Medical School Paris, France
Todd Anderson, M.D. , Director, Foothills Interventional Cardiology Research, Calgary, Alberta
Lawrence J. Appel, M.D, M.P.H. Professor of Medicine, Epidemiology and International Health (Human Nutrition) Johns Hopkins Medical Institutions Baltimore, MD
Naomi Aronson, Ph.D., Executive Director Technology Evaluation Center, Blue Cross and Blue Shield Association Chicago, IL
Robert Balaban, PhD, Director, Laboratory of Cardiac Energetics, NHLBI, NIH
Ruth Barrington, PhD, Chief Executive Officer, Molecular Medicine Ireland, Dublin, Ireland
Thomas Barry, PhD, Molecular Diagnostics Research Group, National University of Ireland, Galway
Philip Barter, The Heart Research Institute Sydney, Australia
Steven R. Bauer, PhD, FDA, Center for Biologics Evaluation & Research, OCTG
Rob Beanlands, MD, Chief, Cardiac Imaging Director, National Cardiac PET Centre, U. Ottawa Heart Institute
Guy Beaulieu, M.D., Science Advisor, Health Canada
Philippe Bedard, MD, FRCP(C), Division of Medical Oncology Drug Development Program, Princess Margaret Hospital University of Toronto
Colin Berry, BSc., Ph.D. Cardiovascular MRI / CV Intervention Program NHLBI, National Institutes of Health Bethesda, MD
Donald M. Black, MD, MBA, Chief Medical Officer, DalCor UK Pharma, Ltd.
Sandra E. Black, MD, FRCP(C), Brill Chair in Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Canada
Melanie Blank, MD, Medical Reviewer, Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, United States Food and Drug Administration (FDA)
Stefan Blankenberg, M.D. Department of Medicine University of Mainz Mainz, Germany
Suzanne Bracken, PhD, Program Officer in Translational Research, Molecular Medicine Ireland
Eric P. Brass, MD, PhD, Prof of Med, Harbor-UCLA Medical Center
Eugene Braunwald, MD, Professor of Medicine, Harvard Medical School
H Bryan Brewer, MD, Medstar Research Institute
B. Greg Brown, M.D., Ph.D. University of Washington Medical Center
David G. Brown, Ph.D., Center for Devices and Radiological Health, FDA
W. Virgil Brown, M.D. Charles Howard Candler Professor of Medicine Emory University School of Medicine Atlanta, GA
Michael A. Brownlee, MD, Albert Einstein College of Medicine
Diarmuid Cahalane, Founder of Open Innovation Partners Ltd, Cork, Ireland
Dolores Cahill, PhD, Professor of Translational Science, University College Dublin, Dublin, Ireland
Robert Califf, MD, Director, Duke Translational Medicine Institute
Gregory Campbell, Ph.D., Director, Division of Biostatistics, Center for Devices and Radiological Health, U.S. Food and Drug Administration
Chris Cannon, M.D. Brigham and Women’s Hospital
Laure Cloarec-Blanchard, MD, Servier International
Patricia Cole, MD, PhD, Director, Global Head, Imaging Biometrics, Esai Medial Research, Inc.
Helen Colhoun, Professor of Public Health, University of Dundee, Scotland
Eric Colman, MD, Deputy Director, Division of Metabolism and Endocrine, Center for Drug Evaluation and Research, FDA
Carolyn C. Compton, M.D., Ph.D., Director, Office of Biorepositories and Biospecimen Research, National Cancer Institute
Gloria Crispino, PhD, Clinicial Trial Statistician, Institute of Technology Tallaght, Dublin, Ireland
Janet Dancey, MD., Director, National Cancer Institute of Canada, Clinical Trials Group, Kingston, Ontario
Simhan Danthi, PhD., Division of Cardiovascular Sciences, NHLBI, NIH
Jean Davignon, M.D. Director Hyperlipidemia and Athero Research Clinical Research Institute of Montreal Professor of Medicine, University of Montreal Montreal, Quebec
Jill Davies, Director of Genetics, Medcan Clinic, Toronto, Ontario
Pim De Feyter, M.D., Professor of Non-invasive Cardiac Imaging, Erasmus University, Rotterdam, the Netherlands
James de Lemos, M.D. Associate Professor and CCU Director University of Texas-Southwestern Medical School Dallas, TX
Clarissa Desjardins, PhD, CEO, Center of Excellence in Personalized Medicine
Marcelo Di Carli, MD, Chief, Nuclear Medicine, Brigham and Women's Hospital
Jay M. Edelberg, M.D., Ph.D. Director, Cardiovascular Biomarkers Clinical Pharmacology & Discovery Medicine GlaxoSmithKline
Elizabeth Eisenhauer, M.D., Chair, Research Action Group, Canadian Partnership Against Cancer
Benjamin Eloff, PhD, Office of the Commissioner, US FDA
Jamie Engert, M.D., Genomic Medicine Center, Chicoutimi Hospital
Zahi A. Fayad, PhD, Professor of Medicine, Mount Sinai School of Medicine
Mark Ferguson, PhD, Director General, Science Foundation Ireland
Giora Feuerstein, M.D. Assistant Vice President Head, Discovery Translational Medicine Wyeth Research
Robert Fiorentino, MD, Medical Reviewer, Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, United States FDA
Brian C. Foster, Therapeutic Products Directorate, Health Products and Food Branch, Health Canada
Felix W. Frueh, Ph.D. Office of Clinical Pharmacology Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Springs, MD
Bruce Furie, M.D. Professor of Medicine Harvard Medical School Boston, MA
Brandon D. Gallas, NIBIB/CDRH Laboratory for the Assessment of Medical Images, FDA, Center for Devices and Radiological Health, Office of Science and Engineering Labs, Division of Imaging and Applied Math
Jean-Jacques Garaud, MD, Head of Global Drug Development, F. Hoffmann-La Roche Ltd.
Alan J. Garber, M.D., Ph. D. Professor, Medicine, Biochemistry, Molecular and Cellular Biology Baylor College of Medicine Houston, TX
Peter Gardiner, Vice President, Medical Affairs & Senior Medical Officer at BG Medicine
Daniel Gaudet M.D., PhD., CRC in preventive genetics, Associate professor of medicine, Université de Montréal, Lipid Clinic, Chicoutimi Hospital
Robert Gerszten, M.D. Professor of Medicine Massachusetts General Hospital Boston, MA
Marcie Glicksman, PhD., Co-Director, Laboratory for Drug Discovery in Neurodegeneration (LDDN), Harvard NeuroDiscovery Center
Anne Goodbody, PhD., Chief Regulatory Officer, Centre for Probe Development and Commercialization, Hamilton, Ontario
Federico Goodsaid, Ph.D. Office of Clinical Pharmacology Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring, MD
Michael Graham, Ph.D., MD, President, Society of Nuclear Medicine
Mark Grant, MD, Tech Evaluation Center, Blue Cross Blue Shield Association
Philip Greenland, M.D. Harry W. Dingman Professor, Preventive Medicine Executive Associate Dean for Clinical and Translational Research Feinberg School of Medicine-Northwestern University
Steven Gutman, MD, Director, Office of In Vitro Diagnostics, FDA
Rory Hachamovitch, M.D., M.Sc., Director of Nuclear Cardiology, University of Southern California Medical Center, Los Angeles, CA
Steven M. Haffner, M.D. Professor of Medicine University of Texas Health Centers San Antonio, TX
Patricia Harlow, Ph.D., Division of Cardiovascular and Renal Products, CDER, FDA
Robert A. Harrington, M.D. Professor of Medicine Duke University Medical Center Durham, NC
Thomas Hatsukami, M.D., Co-Director, Vascular Imaging Laboratory, University of Washington, Seattle, WA
Stanley Hazen, M.D., Ph.D., Director, Center for Cardiovascular Diagnostics and Prevention Section Head, Preventive Cardiology and Rehabilitation, Cleveland Clinic, Cleveland, OH
Jay Heinecke, M.D., Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA
Therese Heinonen, DVM, Director, MHI Coordinating Center and Co-Founder/Exec Dir., CMOD, USA
Sharon Hertz, M.D., Deputy Director Anesthesia, Analgesia, and Rheumatology Products CDER
Karen A. Hicks, MD, Medical Officer, CDER, US FDA
Chris Howard, Solution Architect, IBM Innovation Centre, Dublin, Ireland
Thomas Hudson, M.D., President and Scientific Director, Ontario Institute for Cancer Research, Toronto, CA
Patrice Hugo, PhD., Chief Scientific Officer Clearstone Central Laboratories
Ilan Irony, MD, Clinical Team Leader, DMEP, OND, CDER, US FDA
Narayanan Iyer, BSc, LLB, BCL, Health Canada
Seigo Izumo, M.D., Senior Vice President, Cardiovascular Therapeutics, Gilead Sciences, Inc.
Allan S. Jaffe, M.D. Professor of Medicine Mayo Clinic College of Medicine Rochester, MN
Hylton V. Joffe, MD, Metabolism and Endocrine, CDER, US FDA
Dominique Johnson, PhD, Director, Montreal Health Innovations Coordinating Center (MHICC)
Koen Kas, PhD, Professor, University Ghent, CSO, Pronota, Ghent, Belgium
John J.P. Kastelein, M.D., Ph.D., Department of Vascular Medicine, Academic Medical Center, University of Amsterdam
Cormac Kilty, PhD, Chief Technical Officer, EKF Diagnostics, London, England
Agnes Klein, MD, Director, Center for Evaluation of Radiopharmaceuticals and Biotherapeutics, Health Canada, Ottawa, Canada
Michael Klimas, Ph.D. Executive Director, Imaging Franchise Lead Merck & Co., Inc.
Christoph Koenen, Vice President, Global Medical Affairs, Bristol-Myers Squibb Co.
Wolfgang Koenig, MD, Professor of Medicine and Cardiology, University of Ulm Medical Centre, Ulm, Germany
Ronald M. Krauss, M.D. Senior Scientist and Director, Atherosclerosis Research Children’s Hospital Oakland Research Institute University of California Berkeley, CA
Lewis H. Kuller, M.D., Dr.P.H., Chair, Department of Epidemiology, University of Pittsburgh
Philippe L’Allier, M.D. Associate Director, QCA Core Labs Montreal Heart Institute Montreal, Quebec Canada
Reijo Laaksonen, MD, PhD, Chief Med Officer and Co-Founder, Zora Biosciences, Espoo, Finland
Hanno Langen, PhD, Global Head of Protein and Metabolite Technologies, Hoffmann-LaRoche, Basel, Switzerland
Michael S. Lauer, MD, FACC, FAHA, Director, Division of Cardiovascular Sciences (DCVS) National Heart, Lung, and Blood Institute (NHLBI)
Jeffrey M. Leiden, MD PhD, Managing Director, Clarus Ventures LLC
Lawrence A. Leiter, MD, FRCPC, FACP, Head, Division of Endocrinology & Metabolism, St. Michael’s Hospital, Professor of Medicine & Nutritional Sciences, University of Toronto
Claude Lenfant, M.D. Former Director National Heart, Lung, and Blood Institute
Andrew Levey, MD. Chief, Division of Nephrology, Tufts Medical Center
Daniel Levy, MD Director, Framingham Heart Study Director, Center for Population Studies National Heart, Lung, & Blood Institute Bethesda, MD
Timao Li, Ph.D. Acting Manager, Cardiovascular-Renal Division Bureau of Cardiology, Allergy and Neurological Sciences Therapeutic Products Directorate Health Canada Ottawa, Ontario Canada
Peter Libby, MD, Mallinckrodt Professor of Medicine, Harvard Medical School, Chief of Cardiovascular Medicine, Brigham & Women’s Hospital
Robyn R. Lim, Ph.D., Scientific Advisor, Office of Legislative and Regulatory Modernization, Health Canada
Joao Lima, M.D. Associate Professor of Medicine and Radiology Johns Hopkins Medical School Baltimore, MD
Jonathan R. Lindner, M.D. Associate Professor of Medicine and Associate Chief for Education Cardiovascular Division Oregon Health & Science University Portland, OR
Lance Liotta, MD, PhD, The Center for Applied Proteomics and Molecular Medicine, George Mason University
Ray Lipicky, M.D. Former Director U.S. Food and Drug Administration, Director, LIPICKY LLC
Peter Liu, M.D., Ph.D., Director, Institute of Circulatory and Respiratory Health, Canadian Institutes of Health Research (CIHR), Professor of Medicine, University of Toronto
Eva Lonn, MD, MSc, FRCPC, FACC, Professor of Medicine, McMaster University
Klas Malmberg, MD, PhD, FESC, Karolinska Institutet, Stockholm, Sweden, Clinical Science Leader, F. Hoffman-La Roche Ltd, Basel, Switzerland
G. B. John Mancini, M.D. Professor of Medicine, Division of Cardiology Director, CV Imaging Core Lab Vancouver Hospital Head, Department of Medicine, University of B.C.
Elizabeth Mansfield, Ph.D. Senior Policy Analyst Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health US FDA
Catriona McMahon, MD, Vice-President, Medical Affairs, AstraZeneca Canada Inc.
Jessica L. Mega, M.D., M.P.H., Associate Professor, Harvard Medical School and Associate Physician in Carddiovascular Medicine, Brigham and Women's Hospital
David O. Meltzer, M.D., Ph.D. Director of the Center for Health and Social Sciences Department of Medicine and Dept. of Economics University of Chicago
George A. Mensah, M.D., Chief Medical Officer, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC)
Michele Mercuri, MD, PhD, Vice President, Daiichi-Sankyo Pharma Development
Pierre Meulien, PhD, President and Chief Executive Officer, Genome Canada
George Mills, MD, VP, Medical Imaging Consultant, Perceptive Informatics
Gary F. Mitchell, M.D. Cardiovascular Engineering, Inc. Waltham, MA
Clemens Mittmann, M.D. Federal Institute for Drugs and Medical Devices (BfArM) Bonn, Germany
Jacques Mizrahi, M.D., Head Clinical Research and Exploratory Development Metabolic Diseases, F. Hoffmann-La Roche Ltd.
Alan Moody, Radiologist in Chief, Sunnybrook Health Sciences Centre
Vincent Mooser, MD., Medical Genetics/Clinical Pharmacology And Discovery Medicine, GlaxoSmithKline
David A. Morrow, M.D., MPH TIMI Study Group Cardiovascular Division Brigham and Women’s Hospital Boston, MA
Allison Mueller, Neurology Group Leader Global Regulatory Affairs GE Healthcare Medical Diagnostics R&D
C. Daniel Mullins, PhD, Professor, Pharmacoeconomics, University of Maryland
Elizabeth Nabel, M.D., Director, National Heart, Lung and Blood Institute, National Institutes of Health
Ilaria Nardello, Ph.D., National Coordinator, the Marine Institute, Dublin, Ireland
Steve Nissen, M.D., Chairman, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH
Irene Nunes, OD, PhD, Merck Research Laboratories
Christopher O'Donnell, M.D. Senior Advisor to the Director for Genome Research Associate Director of the Framingham Heart Study NHLBI, National Institutes of Health
Terri O’Grady, RPh, PhD., Canadian Agency for Drugs & Technology in Health
Daniel H. O’Leary, M.D., Chairman, Department of Radiology, New England Medical Center
Oye Olukotun, MD, CEO, CardioVax Inc.
Pat O’Mahony, DVM, MBA, Executive Director, Irish Medicines Board, Chairman, European Medicines Agency (EMA), Dublin, Ireland
David G. Orloff, M.D., Former Director, Division of Metabolism and Endocrinology, FDA and Vice President, Medpace Inc.
James Otvos, PhD., Chief Scientific Officer, LipoScience, Inc., Adjunct Professor, Department of Biochemistry, North Carolina State University
Pamela Ouyang, M.D., Johns Hopkins Bayview Medical Center
Mary Parks, MD, Director, Metabolism and Endocrine, CDER, US FDA
Gerard Pasterkamp, MD, PhD, Chief Scientific Officer, Cavadis; Experimental Cardiology Laboratory, University Medical Center Utrecht, the Netherlands
Michael Perelman, M.D. Vice President, Global Project Mgmt Schering-Plough Research Institute
Marc Pfeffer, M.D., Ph.D. Professor of Medicine Harvard Medical School Brigham and Women’s Hospital Boston, MA
Michael S. Phillips, Ph.D. Director of Pharmacogenomics Genome Quebec Montreal, Quebec
Hubert Pouleur, MD, PhD, Vice President, Cardiovascular-Metabolic Disease Strategy, Pfizer Inc, New York, New York, USA
Robert Powell, PharmD Director, Pharmacometrics Office of Clinical Pharmacology Center for Drug Evaluation and Research US Food and Drug Administration
Aidan Power, Vice President and Head of PharmaTherapeutics Precision Medicine, Pfizer Inc.
Margaret Prescott, M.D. Metabolic and Cardiovascular Research Department Novartis Institute for Biomedical Research Summit, NJ
Joel Raichlen, MD, Senior Director, AstraZeneca
Daniel Rader, M.D. University of Pennsylvania School of Medicine
Paolo Raggi, M.D. Tulane University School of Medicine
Gurvaneet Randhawa, MD, Agency for Healthcare Research and Quality
Patricia Reilly, Member of the Cabinet of Máire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science, Dublin, Ireland
Alan Remaley, MD, PhD, Laboratory of Lipoprotein Metabolism, NHLBI, NIH
Paul Ridker, MD, Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital
Dwaine Rieves, MD, Director, Medical Imaging and Hematology, CDER, US FDA
Eric Rimm, Sc.D. Associate Professor of Epidemiology and Nutrition Harvard School of Public Health Boston, MA
John Rioux, Ph.D. The Laboratory of Genetics and Genomic Medicine of Inflammation Université de Montréal and Montreal Heart Institute
Robert Roberts, MD, FRCP(C), MACC, Director, Ruddy Canadian Cardiovascular Genetics Centre, President & CEO, University of Ottawa Heart Institute
Yves Rosenberg, MD, MPH, Acting Branch Chief, Atherothrombosis and Coronary Artery Disease Branch, NHLBI, NIH
Robert Rosenson, MD, Professor of Medicine, Mt. Sinai School of Medicine
Amy E. Rudolph, Ph.D. Clinical Director Global Medical CV Metabolic Endocrine Pfizer, Inc
Kerry-Anne Rye, The Heart Research Institute, Sydney, Australia
Frank Sacks, M.D. Professor of Cardiovascular Disease Prevention Department of Nutrition Harvard School of Public Health Boston, MA
Patrice Sarrazin, PhD. Senior Scientific Evaluator In Vitro Diagnostic Devices Medical Devices Bureau Therapeutic Product Directorate, Health Canada
William J. Sasiela, Ph.D. Chief Medical Officer Aegerion Pharmaceuticals, Inc.
Ernst Schaefer, M.D. Director, Lipid Metabolism Laboratory Tufts University Boston, MA
Carina Schmidt, MSc, Chief Executive Officer, Athera Biotechnologies, Stockholm, Sweden
Daniel Schultz, M.D. Director, Center for Devices and Radiological Health US Food and Drug Administration Rockville, MD
Sonia Skarlatos, MD, Deputy Dir., Division of CV Sciences, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA
Daniel M. Skovronsky, MD, PhD, Founder and CEO Avid Radiopharmaceuticals
David M. Smalley, PhD, Biomedical Research Facility Cardiovascular Research Center University of Virginia
J. David Spence, M.D. Director, Stroke Prevention and Athero Research Centre Robarts Research Institute London, Ontario, CANADA
George Steiner, M.D. Toronto General Hospital
Norman Stockbridge, MD, Director, Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, FDA
Anders Svensson, MD, Head, Clinical Development, Metabolism, F. Hoffman-La Roche
Alan Tall, M.D., Tiden Weger Bieler Professor of Medicine, Columbia University Medical Center, New York, NY
Jean-Claude Tardif, MD, Director, Montreal Heart Institute (MHI) Research Center; Prof. of Medicine, U of Montreal, Canada Research Chair in translational and personalized medicine
Ahmed Tawakol, MD, Professor of Medicine, Massachusetts General Hospital
Allen J. Taylor, MD, Professor of Medicine, Georgetown University, Department of Medicine, Washington Hospital Center
Doris Taylor, PhD, Director of the Center for Cardiovascular Repair, Stem Cell Institute, University of Minnesota
Robert J. Temple, MD, Deputy Director of Clinical Science, Center for Drug Evaluation and Research, United States FDA
Douglas Throckmorton, MD, Deputy Center Director, Center for Drug Evaluation and Research, United States FDA
Paula R. Trumbo, Ph.D. Team Leader, Nutrition Science Evaluation Center for Food Safety and Applied Nutrition US Food and Drug Administration College Park, MD
Sotirios Tsimikas, M.D., Director, Vascular Medicine, Associate Professor Of Medicine, University of California, San Diego
James E. Udelson, M.D., Chief, Division of Cardiology; Director, Nuclear Cardiology Laboratory; Professor, Tufts University School of Medicine
Roger Ulrich, Ph.D., Fellow ATS, Chief Development Officer, Calistoga Pharmaceuticals Inc. Seattle, Washington
Spiros Vamvakas, Head of Section for Scientific Advice, European Medicines Agency
John Wagner, MD, Ph.D. Director, Clinical Pharmacology Merck & Co., Inc.
Karin Wåhlander, PhD, Vice President for Translational Science, AstraZeneca, Sweden
Marc Walton, MD, PhD, Associate Director, Office of Translational Sciences, Center for Drug Evaluation and Research, United States FDA
G. Russell Warnick, M.S., MBA, Chief Scientific Officer, Sr. VP for Laboratory Operations, Berkeley HeartLab, Inc.
Robert Wasserman, M.D., Vice President and Personalized Healthcare Strategy, F. Hoffmann-La Roche Ltd.
David D. Waters, M.D., Professor Emeritus, University of California, San Francisco
Ralph Weissleder, M.D., Ph.D. Director, Center for Molecular Imaging Research Professor of Radiology, Harvard Medical School Boston, MA
Gerald Willett, MD, Reproductive and Urologic Drug Products, CDER, US FDA
Samuel Wright, PhD, Director, Cardiovascular Therapeutics, CSL Ltd.
Helen Wu, PhD., Research Leader, Genomics & Oncology, Roche Molecular Systems, Inc.
James J. Zhang, M.D., Ph..D., MBA Global Clinical Development Siemens Molecular Imaging, Inc Siemens Medical Solutions USA
Issam Zineh, PharmD, MPH, Associate Director for Genomics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, United States FDA
Bram Zuckerman, M.D. Director, FDA Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health (CDRH)